Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
Open Access
- 27 July 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 63 (2), 220-227
- https://doi.org/10.1212/01.wnl.0000130531.90205.ef
Abstract
Background: Mild cognitive impairment (MCI) is widely viewed as the transition phase between normal aging and Alzheimer disease (AD). Given that MCI can also result from cerebrovascular disease (CVD), the authors used clinical, MRI, and cognitive measures of AD and CVD to test the hypothesis that CVD increases the likelihood of progression from MCI to dementia within 3 years. Objective: To examine the impact of CVD on progression of MCI to dementia. Methods: Fifty-two consecutive patients with MCI (71% men) including many with symptomatic CVD were longitudinally evaluated for 3.1 ± 1.3 years. MCI was defined as a Clinical Dementia Rating Scale (CDR) score of 0.5. Dementia was defined as progression to a CDR score of ≥1.0. Results: Forty-four percent of the MCI patients had MRI infarcts, 50% of which were symptomatic. Thirty-three percent of patients progressed to dementia, and 37.8% of these had MRI infarcts. Clinically probable or possible AD was diagnosed in approximately 82% of converters. Of the clinical and MRI measures, only hippocampal volume was associated with increased risk to progression (hazard ratio [HR] = 0.31 [95% CI 0.1 to 0.92], p = 0.03). When neuropsychological measures were included in the analysis, memory (HR = 0.90 [95% CI 0.84 to 0.96], p = 0.002) and executive function (HR = 0.96 [95% CI 0.92 to 1.0], p = 0.045) were associated with increased risk of dementia progression, whereas APOE genotype, cerebrovascular risk factors, clinical stroke, presence or absence of lacunes, and extent of white matter hyperintensities did not predict progression. Conclusion: Within a heterogenous group of MCI patients, including many with clinically significant CVD, baseline memory and executive performance significantly predicted likelihood to develop dementia.Keywords
This publication has 60 references indexed in Scilit:
- Psychometrically matched measures of global cognition, memory, and executive function for assesment of cognitive decline in older persons.Neuropsychology, 2003
- Silent Brain Infarcts and the Risk of Dementia and Cognitive DeclineNew England Journal of Medicine, 2003
- Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun StudyAnnals of Neurology, 2002
- Executive dysfunction in subcortical ischaemic vascular diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Midlife blood pressure and dementia: the Honolulu–Asia aging study☆Neurobiology of Aging, 2000
- Predictive Value of APOE Genotyping in Incipient Alzheimer's DiseasesaAnnals of the New York Academy of Sciences, 1996
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- Atrophy of the Hippocampal Formation in Early Familial Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 1996
- Validation of clinical diagnostic criteria for Alzheimer's diseaseAnnals of Neurology, 1988
- Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population.Journal of Neurology, Neurosurgery & Psychiatry, 1982